KNSA vs WAT · P/E 53, rev $677.6M vs P/E 32, rev $3.17B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the KNSA and WAT stock pages for the full models.
Not investment advice.